BB20 - BPC 157 + TB 500 - 10/10 MG - Research Use Only

Name: BB20 - BPC 157 + TB 500 - 10/10 MG - Research Use Only
Brand: Peptific
SKU: BB20
Price: 35 USD
Availability: OutOfStock

Wolverine Blend is a dual-peptide research formulation of BPC-157 and Thymosin Beta 4 (TB-500), combining the two most-studied tissue-repair peptides with complementary preclinical mechanisms.

Temporarily unavailable

This product is listed in the catalog, but it is not currently available for ordering. Pricing, specifications, and support details remain visible while launch availability is being finalized.

Select Format

$35.00

Wolverine Blend (BPC-157 / TB-500)-

$35.00

✓HPLC purity tested
✓COA per lot, on request
✓Lyophilized, sealed
✓US shipping, tracked

Combines BPC-157's gut and tendon repair research with TB-500's cardiac and systemic repair profile
Mechanistically complementary — targets both localized connective tissue and systemic cell migration repair pathways
Most commonly studied peptide pairing in preclinical tissue-repair research literature
Convenient single-vial formulation for research protocols requiring both compounds
Covers both NO-system angiogenesis research (BPC-157) and actin-regulation repair research (TB-500)

✓

Free shipping on orders over $150

Research Supplies

Need bacteriostatic water, syringes, or an alcohol prep kit? Email us — we can bundle reconstitution supplies with your order.

Ask about a research kit →

Need the COA before you order? Request it here.

In your order

What ships when you order Wolverine Blend (BPC-157 / TB-500)

Lyophilized vial
Sterile-filtered, freeze-dried peptide in glass vial, sealed under inert gas.
Lot ID on every vial
Printed lot ID ties this exact vial to its analytical record.
COA on request
Independent third-party HPLC certificate, matched to your lot, sent on request.
Carrier-tracked shipping
Shipped from a US facility with full carrier tracking and protective packaging.

The Peptific standard

Why researchers buy from Peptific instead of grey-market vendors

Peptide quality is invisible until it isn’t. Lot identity, purity, fill integrity, and chain of custody are the difference between usable research material and wasted budget.

Third-party HPLC tested
Every lot is tested for identity and purity by an independent analytical lab. Certificate of Analysis available on request, tied to the exact lot you receive.
Lyophilized and lot-tracked
Sterile-filtered, freeze-dried, sealed under inert gas. Each vial carries its own lot ID — full chain of custody from fill to delivery.
US-based fulfillment
Orders ship from a temperature-controlled US facility with carrier tracking. No drop-shipping, no opaque overseas relay.
Real support, not a ticket queue
A real person responds to research questions, lot questions, and order questions — usually same business day. No bot triage.

How it works

The Wolverine Blend (BPC-157 / TB-500) mechanism

BPC-157 in the blend operates through NO-system interaction and localized angiogenesis promotion in connective tissue models. TB-500 complements this through actin-G sequestration, promoting cell migration and systemic tissue repair across cardiac, dermal, and musculoskeletal injury models. The combination targets different nodes of the tissue repair cascade simultaneously.

Compound profile

Components: BPC-157 + Thymosin Beta 4 (TB-500)
BPC-157 class: Pentadecapeptide, 15 amino acids
TB-500 class: Actin-sequestering peptide, 43 amino acids
Research category: Combined tissue repair, musculoskeletal, cardiac
Format: Lyophilized blend (single vial)
Storage: Lyophilized: −20°C. Reconstituted: 2–8°C, use within 30 days

Product definition

What is Wolverine Blend (BPC-157 / TB-500)?

Wolverine Blend is a dual-peptide research formulation of BPC-157 and Thymosin Beta 4 (TB-500), combining the two most-studied tissue-repair peptides with complementary preclinical mechanisms.

The Wolverine Blend is a combined research formulation containing BPC-157 (Body Protection Compound 157) and Thymosin Beta 4 (TB-500). Both compounds have extensive independent preclinical research profiles, and the combination has become one of the most commonly studied peptide pairings in the tissue-repair research literature. BPC-157 is a 15-amino-acid pentadecapeptide derived from gastric protein, studied for tendon healing, gut-barrier protection, angiogenesis, and neuroprotective effects in animal models. TB-500 is a 43-amino-acid actin-binding peptide studied for cardiac muscle repair, wound closure acceleration, hair follicle activation, and systemic anti-inflammatory effects. Their proposed mechanisms are distinct and complementary, targeting different aspects of the tissue repair cascade.

Research audience

Who studies Wolverine Blend (BPC-157 / TB-500)?

The Wolverine Blend is used by researchers in musculoskeletal repair, sports medicine preclinical work, post-injury tissue remodeling research, and cardiac recovery studies. It is favored when research protocols call for both compounds and single-vial convenience reduces preparation complexity.

Research context

What does the preclinical literature say about Wolverine Blend (BPC-157 / TB-500)?

The combination of BPC-157 and TB-500 emerged as a research pairing because researchers studying repair mechanisms noted that the two peptides target distinct but parallel nodes of the tissue repair process. BPC-157 literature documents activity primarily in localized injury models — Achilles tendon, gastric ulceration, anastomotic repair — through proposed NO-system and VEGF pathway interactions. TB-500 literature documents activity primarily in systemic models — myocardial infarction, cutaneous wounds, hair regrowth — through actin regulation and cell migration mechanisms. In practical research terms, the Wolverine Blend (5 mg BPC-157 + 5 mg TB-500 or 10 mg + 10 mg) is used when investigators want to study both mechanisms without managing two separate lyophilized compounds. The formulation is particularly common in orthopedic and sports science preclinical research where both localized connective tissue repair and systemic healing mechanisms are of interest.

Common questions

Why combine BPC-157 and TB-500 rather than use each separately?

The combination is used when research protocols require coverage of both localized connective tissue repair mechanisms (BPC-157's primary research area) and systemic cell-migration and cardiac repair mechanisms (TB-500's primary research area). Using a pre-blended formulation reduces preparation complexity in multi-compound protocols.

Does combining them affect the activity of either compound?

No studies to date indicate negative interaction between BPC-157 and TB-500 in combination. The mechanisms are proposed to be distinct and non-competing. Some animal studies have specifically used the combination to examine synergistic or additive effects in injury models.

Which blend ratio should researchers select?

Peptific offers two ratios: 5 mg BPC-157 / 5 mg TB-500 and 10 mg BPC-157 / 10 mg TB-500. Ratio selection depends on the specific research protocol and study duration requirements. The higher dose formulation is generally used in longer-duration or larger animal preclinical studies.